PER-1 is still widespread in Turkish hospitals among Pseudomonas aeruginosa and Acinetobacter spp.

被引：50

作者：

Kolayli, F

Gacar, G

Karadenizli, A

Sanic, A

Vahaboglu, H

机构：

[1] Kocaeli Univ, Mikrob Klin Mikrob AD, Kocaeli, Turkey

[2] Ondokuzmays Univ, Mikrob Klin Mikrob AD, Samsun, Turkey

[3] Kocaeli Univ, Enfeksiyon Hastalklar Klin Mikrobiyoloji AD, Kocaeli, Turkey

[4] Ankara Univ, TR-06100 Ankara, Turkey

[5] Univ Istanbul, Istanbul, Turkey

[6] Erciyes Univ, Erciyes, Turkey

[7] Karadeniz Tekn Univ, Karadeniz, Turkey

[8] Ondokuz Mayis Univ, TR-55139 Kurupelit, Turkey

[9] Ege Univ, Izmir, Turkey

来源：

FEMS MICROBIOLOGY LETTERS | 2005年 / 249卷 / 02期

关键词：

Acinetobacter; Pseudomonas; antibiotic resistance; beta-lactamase;

D O I：

10.1016/j.femsle.2005.06.012

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

PER-1 type beta-lactamases were screened among ceftazidime-resistant clinical isolates of Acinetobacter spp. and Pseudomonas aeruginosa. A total of 176 non-repetitive isolates (84 Acinetobacter spp. and 92 P. aeruginosa) were collected during a three month surveillance period. Isolates were obtained from seven intensive care units of seven university hospitals. All strains were screened for bla(PER-1) alleles by PCR. Of the strains, 31% and 55.4% of Acinetobacter spp. and P. aeruginosa were positive for bla(PER-1) type genes, respectively. (c) 2005 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.

引用

收藏

页码：241 / 245

页数：5

相关论文

共 19 条

[1] Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii [J].

Afzal-Shah, M ;

Woodford, N ;

Livermore, DM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) :583-588

[2] Surveillance of antimicrobial resistance among Gram-negative isolates from intensive care units in eight hospitals in Turkey [J].

Aksaray, S ;

Dokuzoguz, B ;

Güvener, E ;

Yücesoy, M ;

Yulug, N ;

Kocagöz, S ;

Ünal, S ;

Çetin, S ;

Calangu, S ;

Günaydin, M ;

Leblebicioglu, H ;

Esen, S ;

Bayar, B ;

Willke, A ;

Findik, D ;

Tuncer, I ;

Baysal, B ;

Günseren, F ;

Mamikoglu, L .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (05) :695-699

[3] PER-1 β-lactamase-producing Pseudomonas aeruginosa in an intensive care unit [J].

Claeys, G ;

Verschraegen, G ;

de Baere, T ;

Vaneechoutte, M .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (06) :924-925

[4] Prospective survey of β-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolated in a French hospital in 2000 [J].

De Champs, C ;

Poirel, L ;

Bonnet, R ;

Sirot, D ;

Chanal, C ;

Sirot, J ;

Nordmann, P .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (09) :3031-3034

[5] Relationship between β-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii [J].

Fernández-Cuenca, F ;

Martínez-Martínez, L ;

Conejo, MC ;

Ayala, JA ;

Perea, EJ ;

Pascual, A .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (03) :565-574

[6] IMIPENEM RESISTANCE IN ACINETOBACTER-BAUMANNII IS DUE TO ALTERED PENICILLIN-BINDING PROTEINS [J].

GEHRLEIN, M ;

LEYING, H ;

CULLMANN, W ;

WENDT, S ;

OPFERKUCH, W .

CHEMOTHERAPY, 1991, 37 (06) :405-412

[7] A surveillance study of antimicrobial resistance of Gram-negative bacteria isolated from intensive care units in eight hospitals in Turkey [J].

Günseren, F ;

Mamikoglu, L ;

Öztürk, S ;

Yücesoy, M ;

Biberoglu, K ;

Yulug, N ;

Doganay, M ;

Sümerkan, B ;

Kocagöz, S ;

Ünal, S ;

Çetin, S ;

Çalangu, S ;

Köksal, I ;

Leblebicioglu, H ;

Günaydin, M .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (03) :373-378

[8] Carbapenem activities against Pseudomonas aeruginosa:: Respective contributions of OprD and efflux systems [J].

Köhler, T ;

Michea-Hamzehpour, M ;

Epp, SF ;

Pechere, JC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (02) :424-427

[9] Surveillance of antimicrobial resistance in Gram-negative isolates from intensive care units in Turkey: Analysis of data from the last 5 years [J].

Leblebicioglu, H ;

Gunaydin, M ;

Esen, S ;

Tuncer, I ;

Findik, D ;

Ural, O ;

Saltoslu, N ;

Yaman, A ;

Tasova, Y .

JOURNAL OF CHEMOTHERAPY, 2002, 14 (02) :140-146

[10] ROLE OF EFFLUX PUMP(S) IN INTRINSIC RESISTANCE OF PSEUDOMONAS-AERUGINOSA - ACTIVE EFFLUX AS A CONTRIBUTING FACTOR TO BETA-LACTAM RESISTANCE [J].

LI, XZ ;

MA, D ;

LIVERMORE, DM ;

NIKAIDO, H .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (08) :1742-1752